C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

Caidya

01

Dec 2022

Argenx Enters Into Agreement To Acquire Priority Review Voucher

Argenx SE a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases today announced an agreement to acquire a US Food and Drug Administration FDA Priority Review Voucher PRV for million A PRV entitles the holder to FDA priority review of a sing...

01

Dec 2022

BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates

BioNTech SE and Ryvu Therapeutics SA a clinicalstage company developing oncology therapeutics today announced that the companies have entered into a multitarget research collaboration for several small molecule immunotherapy programs as well as an exclusive license agreement for Ryvus STING agonist...

30

Nov 2022

Ribon Therapeutics Announces Acquisition of Pre-Clinical CD38 Program by Boehringer Ingelheim

Ribon Therapeutics a clinical stage biotechnology company developing therapeutics targeting stress support pathways today announced that it entered into an agreement on the acquisition of its CD program with Boehringer Ingelheim This includes a small molecule inhibitor designed to modulate intra and...

30

Nov 2022

Envisagenics Announces Research Collaboration with Bristol Myers Squibb

Envisagenics an Artificial Intelligence AIdriven biotechnology company that delivers therapies for RNA splicing diseases today announced a research collaboration agreement with Bristol Myers Squibb The multiyear collaboration will leverage Envisagenics SpliceCore AI platform to identify alternative...

29

Nov 2022

Clinigen adds pharmacovigilance capabilities with acquisition of Drug Safety Navigator

Clinigen Limited the global pharmaceutical services company has agreed to acquire Drug Safety Navigator Inc DSN a specialist pharmacovigilance service provider based in the US This acquisition enables Clinigen to add vital pharmacovigilance capabilities to its leading pharma services offering for ph...

29

Nov 2022

ANI Pharmaceuticals Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP

ANI Pharmaceuticals Inc announced that the Company received US Food and Drug Administration FDA approval for the Abbreviated New Drug Application ANDA for Fluoxetine Oral Solution USP mg mL ANIs Fluoxetine Oral Solution is the generic version of the Reference

press releasesRead more...

30

Nov 2022

Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Agreement with Pharmaceutical Research & Development Company, Sarfez Pharmaceuticals, Inc.

Novo Integrated Sciences Inc and Clinical Consultants International LLC CCI a Novo whollyowned subsidiary today announced the signing of a Consulting Agreement the Agreement with Sarfez Pharmaceuticals Inc Sarfez a pharmaceutical research and development company with an FDAapproved edema treatment f...

30

Nov 2022

IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies

IPA an advanced biotherapeutic research and technology company today announced that BioStrand BV an AI in silico discovery subsidiary of IPA has entered into a research collaboration and license agreement the Agreement with BriaCell Therapeutics Corp a clinicalstage biotechnology company specializin...

29

Nov 2022

Eikonoklastes Therapeutics and Forge Biologics Announce Viral Vector Contract Development and AAV Manufacturing Partnership

Eikonoklastes Therapeutics a preclinical biotech company developing treatments for todays most challenging diseases and Forge Biologics a gene therapyfocused contract development and manufacturing organization today announced a manufacturing partnership that will advance Eikonoklastes AAVbased gene...

29

Nov 2022

Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa

Bioventure a Dubaibased pharmaceutical company Minapharm Pharmaceuticals a Cairobased pharmaceutical company and MiGenTra GmbH a Berlinbased pharmaceutical company announced today the signing of an exclusive license agreement for the commercialization of multiple biosimilar candidates developed and...

29

Nov 2022

AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy

Neogene Therapeutics Inc a global clinicalstage biotechnology company pioneering the discovery development and manufacturing of nextgeneration Tcell receptor therapies TCRTs today announced it has entered into a definitive agreement to be acquired by AstraZeneca With a shared goal of bringing cell t...

29

Nov 2022

Azelis strengthens pharmaceutical offering in India through distribution partnership with leading vitamin producer Royal DSM

Azelis a leading innovation service provider in the specialty chemicals and food ingredients industry is pleased to announce a distributor partnership with Royal DSM DSM a global leader in health and nutrition Effective immediately this mandate strengthens and expands Azelis Pharmaceuticals Healthc...

EventsRead more...

29 - 01

Nov 2022

Obesity and NASH Drug Development

Hanson Wade
Revere Hotel Boston Common

29 - 01

Nov 2022

CRISPR 2.0 Summit 2022

Hanson Wade
Hilton Boston Back Bay

29 - 01

Nov 2022

Inflammasome Therapeutics Summit

Hanson Wade
Boston Park Plaza

30 - 01

Nov 2022

Outsourcing in Clinical Trials DACH 2022

Holiday Inn Munich City Centre

30 - 02

Nov 2022

Dry AMD Therapeutics Summit

Hanson Wade
Revere Hotel Boston Common

02 - 02

Dec 2022

BioSpectrum Asia Excellence Awards

MMACTIV Singapore Pte Ltd
Hotel Fort Canning

05 - 08

Dec 2022

Gene Therapy for Neurological Disorders

Hanson Wade
The Westin Seaport District

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    University of Lincoln, UK

    Senior Lecturer, School of Pharmacy

    Ishwar Singh is a Senior Lecturer in Biological Chemistry at the School of Pharmacy University of Lincoln Prior to Lincoln he had held many prestigious fellowships such as the Alexander von Humboldt fellowship Germany and Senior Research Fellowship DANIDA Denmark and CSIR India He is an organic chemist He has developed bioconjugations for DNA RNA and polymer modifications in water He is currently...
  • Articles

    Nano-Carrier based Smart Drug Delivery Systems

    Cancer is one of the leading causes of death but is surpassed by cardiovascular diseases Chemotherapy plays a vital role in treating undetectable cancer microfocuses and free cancer cells Chemotherapy utilises chemical substances to kill or stop cancer cell development regarding that cancer cells are developed often much faster than those are healthy ones

  • Case Studies

    Analytics Stories: A Case Study from Quintiles

    As I have shared within other posts within this series businesses are using analytics to improve their internal and external facing business processes and to strengthen their right to win within the markets that they operate For pharmaceutical businesses strengthening the right to win begins and ends with the drug product development lifecycle I remember for example t...

  • Techno Trends

    Novel ZetaMet™ Technology Discovered for Metastatic Bone Cancers

    Zetagen Therapeutics discovered novel ZetaMet technology for the treatment of metastatic bone cancers This technology is the first to suspend cancer inhibit pain and regenerate bone ZetaMet technology was earlier known as ZetaFuse It is a synthetic smallmolecule inductive biologic technology introduced to target and resolve metastatic

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...